• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adjusted carbohydrate antigen 19-9. Correlation with histological grade in pancreatic adenocarcinoma.

作者信息

Ortiz-González Jorge, Alvarez-Aguila Nora Patricia, Medina-Castro Juan Manuel

机构信息

Department of Surgical Oncology, National Institute of Cancerology, México DF, México.

出版信息

Anticancer Res. 2005 Sep-Oct;25(5):3625-7.

PMID:16101191
Abstract

BACKGROUND

The serum level of carbohydrate antigen 19-9 (CA 19-9) depends on the tumor size and differentiation grade. Jaundice can cause an elevation of serum CA 19-9, although the nature of this interaction is not fully understood.

PATIENTS AND METHODS

This was a retrospective study of 26 patients with potentially resectable pancreatic adenocarcinoma. Serum CA 19-9 was correlated with the histological differentiation. CA 19-9 adjusted for serum bilirubin was determined and analyzed.

RESULTS

No correlation between CA 19-9 and histological differentiation was determined (p>0.05). The median adjusted CA 19-9 level was significantly lower (p=0.01) in patients with normal biliary excretion than those with bilirubin levels >2 mg/dL.

CONCLUSION

These data are consonant with the theory of a dual contribution to the serum CA 19-9 level from biliary obstruction and tumor cell synthesis.

摘要

相似文献

1
Adjusted carbohydrate antigen 19-9. Correlation with histological grade in pancreatic adenocarcinoma.
Anticancer Res. 2005 Sep-Oct;25(5):3625-7.
2
The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer.使用调整后的术前CA 19-9预测可切除胰腺癌的复发情况。
J Surg Res. 2007 Jun 1;140(1):31-5. doi: 10.1016/j.jss.2006.10.007. Epub 2007 Apr 9.
3
Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.术前血清癌胚抗原和糖类抗原19-9水平用于评估胰腺腺癌患者的可治愈性和可切除性。
J Hepatobiliary Pancreat Surg. 2007;14(6):539-44. doi: 10.1007/s00534-006-1184-3. Epub 2007 Nov 30.
4
Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.可切除胰腺癌患者围手术期血清 CA19-9 水平的预后影响。
Ann Surg Oncol. 2010 Sep;17(9):2321-9. doi: 10.1245/s10434-010-1033-0. Epub 2010 Mar 25.
5
Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma.糖类抗原19-9和杜克胰腺单克隆抗原2水平升高均反映胰腺癌患者的术后预后。
Pancreas. 2009 Aug;38(6):619-24. doi: 10.1097/MPA.0b013e3181a53ee7.
6
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
J Clin Oncol. 2006 Dec 10;24(35):5610; author reply 5611. doi: 10.1200/JCO.2006.08.4798.
7
Expression of tumor-associated carbohydrate antigens correlates with hepatic metastasis of pancreatic cancer: clinical and experimental studies.肿瘤相关碳水化合物抗原的表达与胰腺癌肝转移的相关性:临床与实验研究
Hepatogastroenterology. 1996 May-Jun;43(9):748-55.
8
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.肿瘤标志物CA19-9升高:临床解读及梗阻性黄疸的影响
Eur J Surg Oncol. 2000 Aug;26(5):474-9. doi: 10.1053/ejso.1999.0925.
9
[Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].
Wiad Lek. 2003;56(11-12):537-40.
10
Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.术前血清CA19-9及胰腺周围组织切缘作为胰腺癌长期生存的决定因素
Ann Surg Oncol. 2009 May;16(5):1231-40. doi: 10.1245/s10434-009-0415-7. Epub 2009 Mar 5.

引用本文的文献

1
Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With Histological Grade in a Chinese Population.中国人群中胰腺导管腺癌患者血清高密度脂蛋白胆固醇浓度及其与组织学分级的关系
Cancer Control. 2025 Jan-Dec;32:10732748251316602. doi: 10.1177/10732748251316602.
2
Preoperative Alkaline Phosphatase-adjusted CA19-9 as a Superior Prognosticator for Extrahepatic Biliary Tract Cancer With Jaundice.术前碱性磷酸酶校正的CA19-9作为黄疸型肝外胆管癌的优越预后指标。
Cancer Diagn Progn. 2022 Sep 3;2(5):569-575. doi: 10.21873/cdp.10144. eCollection 2022 Sep-Oct.
3
The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study.
CA19-9/TBIL比值在胆道癌(BTCs)患者中的预后价值:一项回顾性研究
J Oncol. 2021 Feb 23;2021:5829893. doi: 10.1155/2021/5829893. eCollection 2021.
4
Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria.根据新的国际共识标准,胰腺头部癌的边缘可切除性对患者生存的影响:生物学因素至关重要
Ann Surg Oncol. 2021 Apr;28(4):2325-2336. doi: 10.1245/s10434-020-09100-6. Epub 2020 Sep 12.
5
Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ratio with the McGill Brisbane Symptom Score.胰腺癌与生存预测因素:比较CA 19-9/胆红素比值与麦吉尔布里斯班症状评分
HPB (Oxford). 2013 Dec;15(12):1002-9. doi: 10.1111/hpb.12085. Epub 2013 Mar 22.
6
Adjusting CA19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and C-reactive protein.调整 CA19-9 值以预测阻塞性黄疸中的恶性肿瘤:胆红素和 C 反应蛋白的影响。
World J Gastroenterol. 2012 Aug 21;18(31):4150-5. doi: 10.3748/wjg.v18.i31.4150.
7
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.血清 CA 19-9 在胰腺腺癌的诊断、预后和管理中的临床应用:基于证据的评估。
J Gastrointest Oncol. 2012 Jun;3(2):105-19. doi: 10.3978/j.issn.2078-6891.2011.021.
8
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.血清CA 19-9作为胰腺癌生物标志物的综合综述。
Indian J Surg Oncol. 2011 Jun;2(2):88-100. doi: 10.1007/s13193-011-0042-1. Epub 2011 Feb 17.
9
Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.胰腺癌相关恶病质:对代谢的影响以及与体重减轻和肺功能的相关性。
BMC Cancer. 2009 Jul 28;9:255. doi: 10.1186/1471-2407-9-255.